This presentation will review what we know of how regulatory agencies are working together internationally to share best practices in reviewing drugs.
We will discuss Tier 1, 2, 3, and other regulatory agencies and how the approach to international reviews varies from agency to agency. We will discuss whether the European paradigm can be applied more broadly, and what the impact of ICH and CIOMS has to the international sharing of data.
Compliance4All
Adam Fleaming
Phone: +1-800-447-9407
Event Link: http://bit.ly/1GLLNZI
[email protected]
www.compliance4all.com
This presentation will review what we know of how regulatory agencies are working together internationally to share best practices in reviewing drugs.
We will discuss Tier 1, 2, 3, and other regulatory agencies and how the approach to international reviews varies from agency to agency. We will discuss whether the European paradigm can be applied more broadly, and what the impact of ICH and CIOMS has to the international sharing of data.
Compliance4All
Adam Fleaming
Phone: +1-800-447-9407
Event Link: http://bit.ly/1GLLNZI
[email protected]
www.compliance4all.com
This presentation will review what we know of how regulatory agencies are working together internationally to share best practices in reviewing drugs.
We will discuss Tier 1, 2, 3, and other regulatory agencies and how the approach to international reviews varies from agency to agency. We will discuss whether the European paradigm can be applied more broadly, and what the impact of ICH and CIOMS has to the international sharing of data.
Compliance4All
Adam Fleaming
Phone: +1-800-447-9407
Event Link: http://bit.ly/1GLLNZI
[email protected]
www.compliance4all.com
will be held in Fremont,United States on date 2015-07-09